224 related articles for article (PubMed ID: 11858867)
1. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
Jacquet A; Haumont M; Massaer M; Garcia L; Mazzu P; Daminet V; Grégoire D; Jacobs P; Bollen A
Vaccine; 2002 Feb; 20(11-12):1593-602. PubMed ID: 11858867
[TBL] [Abstract][Full Text] [Related]
2. Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity.
Sadzot-Delvaux C; Arvin AM; Rentier B
J Infect Dis; 1998 Nov; 178 Suppl 1():S43-7. PubMed ID: 9852972
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of Varicella Zoster Virus DNA Vaccines Encoding Glycoprotein E and Immediate Early Protein 63 in Mice.
Liu J; Lin J; Cai L; Sun J; Ding X; Wang C; Wu Y; Gao X; Su W; Jiang C
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746685
[TBL] [Abstract][Full Text] [Related]
4. Differential neutralizing antibody responses to varicella-zoster virus glycoproteins B and E following naked DNA immunization.
Massaer M; Haumont M; Garcia L; Mazzu L; Bollen A; Jacobs P; Jacquet A
Viral Immunol; 1999; 12(3):227-36. PubMed ID: 10532651
[TBL] [Abstract][Full Text] [Related]
5. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
[TBL] [Abstract][Full Text] [Related]
6. Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis.
Kimura H; Wang Y; Pesnicak L; Cohen JI; Hooks JJ; Straus SE; Williams RK
J Infect Dis; 1998 Aug; 178(2):310-7. PubMed ID: 9697709
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical identification of varicella-zoster virus gene 63-encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use.
Nikkels AF; Debrus S; Sadzot-Delvaux C; Piette J; Rentier B; Piérard GE
J Med Virol; 1995 Dec; 47(4):342-7. PubMed ID: 8636701
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
[TBL] [Abstract][Full Text] [Related]
9. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
Baiker A; Bagowski C; Ito H; Sommer M; Zerboni L; Fabel K; Hay J; Ruyechan W; Arvin AM
J Virol; 2004 Feb; 78(3):1181-94. PubMed ID: 14722273
[TBL] [Abstract][Full Text] [Related]
10. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
Lowry PW; Koropchak CM; Choi CY; Mocarski ES; Kern ER; Kinchington PR; Arvin AM
Antiviral Res; 1997 Feb; 33(3):187-200. PubMed ID: 9037375
[TBL] [Abstract][Full Text] [Related]
11. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
Garcia-Valcarcel M; Fowler WJ; Harper DR; Jeffries DJ; Layton GT
Vaccine; 1997; 15(6-7):709-19. PubMed ID: 9178473
[TBL] [Abstract][Full Text] [Related]
12. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
Schmid DS; Miao C; Leung J; Johnson M; Weinberg A; Levin MJ
J Virol; 2021 May; 95(12):. PubMed ID: 33762414
[TBL] [Abstract][Full Text] [Related]
13. Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice.
Wui SR; Kim KS; Ryu JI; Ko A; Do HTT; Lee YJ; Kim HJ; Lim SJ; Park SA; Cho YJ; Kim CG; Lee NG
Vaccine; 2019 Apr; 37(15):2131-2141. PubMed ID: 30827737
[TBL] [Abstract][Full Text] [Related]
14. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
[TBL] [Abstract][Full Text] [Related]
15. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells.
Haumont M; Jacquet A; Massaer M; Deleersnyder V; Mazzu P; Bollen A; Jacobs P
Virus Res; 1996 Feb; 40(2):199-204. PubMed ID: 8725116
[TBL] [Abstract][Full Text] [Related]
16. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
Fowler WJ; Garcia-Valcarcel M; Hill-Perkins MS; Murphy G; Harper DR; Jeffries DJ; Burns NR; Adams SE; Kingsman AJ; Layton GT
Virology; 1995 Dec; 214(2):531-40. PubMed ID: 8553555
[TBL] [Abstract][Full Text] [Related]
17. Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens.
Iwasaki T; Muraki R; Kasahara T; Sato Y; Sata T; Kurata T
Arch Virol Suppl; 2001; (17):109-19. PubMed ID: 11339540
[TBL] [Abstract][Full Text] [Related]
18. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
[TBL] [Abstract][Full Text] [Related]
19. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM
J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P
J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
